Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (20249)	4/2/1999 4:27:00 PM
From: DaiS	Read Replies (2) \| Respond to of 23519

Vlad, Pfizer has a 20% EPS growth rate to help justify its 90-100 year multiple. So in 12 years Pfizer will be selling 8 times more drugs to joyful US citizens. I guess that your ever increasing wealth will happily cover the increase in health insurance that this demands. There was an article in my newspaper today about how the continued upward climb of tech related stocks in the US is being fuelled by herding behaviour of an ever increasing number of day traders as well as vested interests. To hell with the intrinsic underlying value of a share certificate, what intrinsic value does a bar of gold have! So maybe there never will be a tulipomania like bust. DaiS